Zioptan



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 71.5%
Intraocular Pressure Increased 11.0%
Intraocular Pressure Test 4.7%
Open Angle Glaucoma 4.1%
Normal Tension Glaucoma 1.7%
Macular Degeneration 1.2%
Abnormal Sensation In Eye 0.6%
Chronic Obstructive Pulmonary Disease 0.6%
Conjunctivitis 0.6%
Eye Disorder 0.6%
Intraocular Pressure Decreased 0.6%
Intraocular Pressure Test Abnormal 0.6%
Prophylaxis 0.6%
Sinus Disorder 0.6%
Thrombophlebitis 0.6%
Type 2 Diabetes Mellitus 0.6%
Vision Blurred 15.6%
Ocular Hyperaemia 14.9%
No Adverse Event 8.4%
Urinary Tract Infection 5.8%
Eye Pain 5.2%
Pruritus 5.2%
Headache 4.5%
Overdose 4.5%
Eye Pruritus 3.9%
Intraocular Pressure Increased 3.9%
Product Quality Issue 3.9%
Arthralgia 3.2%
Nasopharyngitis 3.2%
Visual Acuity Reduced 3.2%
Dyspnoea 2.6%
Eye Irritation 2.6%
Lip Swelling 2.6%
Rash 2.6%
Corneal Erosion 1.9%
Drug Ineffective 1.9%
Secondary
Glaucoma 50.0%
Product Used For Unknown Indication 17.6%
Intraocular Pressure Test Abnormal 5.9%
Normal Tension Glaucoma 5.9%
Conjunctivitis 2.9%
Crohn's Disease 2.9%
Insomnia 2.9%
Intraocular Pressure Increased 2.9%
Intraocular Pressure Test 2.9%
Open Angle Glaucoma 2.9%
Pain 2.9%
Eye Pruritus 10.0%
Ocular Hyperaemia 10.0%
Vision Blurred 10.0%
Blepharal Pigmentation 5.0%
Blepharospasm 5.0%
Cataract 5.0%
Dizziness 5.0%
Eye Irritation 5.0%
Growth Of Eyelashes 5.0%
Hypersensitivity 5.0%
Intraocular Pressure Fluctuation 5.0%
Intraocular Pressure Increased 5.0%
Off Label Use 5.0%
Rash 5.0%
Vertigo 5.0%
Visual Acuity Reduced 5.0%
Wound Haemorrhage 5.0%
Concomitant
Glaucoma 28.8%
Product Used For Unknown Indication 19.2%
Intraocular Pressure Increased 8.2%
Cancer Pain 6.8%
Insomnia 4.1%
Open Angle Glaucoma 4.1%
Pain 4.1%
Blepharitis 2.7%
Dry Eye 2.7%
Keratitis 2.7%
Oedema 2.7%
Supportive Care 2.7%
Apraxia 1.4%
Blepharospasm 1.4%
Blood Cholesterol Increased 1.4%
Constipation 1.4%
Cough 1.4%
Crohn's Disease 1.4%
Diabetes Mellitus 1.4%
Haemorrhage Prophylaxis 1.4%
Vision Blurred 15.4%
Product Quality Issue 11.5%
Wrong Technique In Drug Usage Process 7.7%
Conjunctival Hyperaemia 3.8%
Dysphonia 3.8%
Eye Pain 3.8%
Grand Mal Convulsion 3.8%
Headache 3.8%
Inappropriate Schedule Of Drug Administration 3.8%
Incorrect Drug Administration Duration 3.8%
Lacrimation Increased 3.8%
Ocular Hyperaemia 3.8%
Pain 3.8%
Product Container Issue 3.8%
Product Packaging Quantity Issue 3.8%
Pruritus 3.8%
Scleral Hyperaemia 3.8%
Sensory Level Abnormal 3.8%
Throat Tightness 3.8%
Type V Hyperlipidaemia 3.8%